Ontology highlight
ABSTRACT: Purpose of review
Due to the findings of current studies and the approval of novel substances for the therapy of hormone-receptor-positive breast cancer patients, the established standards of endocrine treatment are changing. The purpose of this review is to give an overview of the history of endocrine treatment, to clarify its role in the present standard of care, and to discuss the possibilities of improvement.Recent findings
Tamoxifen, aromatase inhibitors, and fulvestrant are the main drugs that have been used for decades in the therapy of hormone-receptor-positive breast cancer patients. However, since a relevant number of women suffer at some point from disease recurrence or progression, several novel substances are being investigated to overcome resistance mechanisms
SUBMITTER: Nabieva N
PROVIDER: S-EPMC8616153 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature